| 000 | 01886 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516022917.0 | ||
| 264 | 0 | _c20110808 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1995-9133 | ||
| 024 | 7 |
_a10.1016/S1684-1182(10)60031-X _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYang, Ya-Sung | |
| 245 | 0 | 0 |
_aImpact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections. _h[electronic resource] |
| 260 |
_bJournal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi _cJun 2010 |
||
| 300 |
_a194-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAPACHE |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCommunity-Acquired Infections _xdrug therapy |
| 650 | 0 | 4 | _aCritical Care |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKlebsiella Infections _xdrug therapy |
| 650 | 0 | 4 |
_aKlebsiella pneumoniae _xdrug effects |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aUrinary Catheterization |
| 650 | 0 | 4 |
_aUrinary Tract Infections _xdrug therapy |
| 650 | 0 | 4 |
_abeta-Lactamases _xmetabolism |
| 700 | 1 | _aKu, Chih-Hung | |
| 700 | 1 | _aLin, Jung-Chung | |
| 700 | 1 | _aShang, Shih-Ta | |
| 700 | 1 | _aChiu, Chun-Hsiang | |
| 700 | 1 | _aYeh, Kuo-Ming | |
| 700 | 1 | _aLin, Chu-Chun | |
| 700 | 1 | _aChang, Feng-Yee | |
| 773 | 0 |
_tJournal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi _gvol. 43 _gno. 3 _gp. 194-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1684-1182(10)60031-X _zAvailable from publisher's website |
| 999 |
_c20570482 _d20570482 |
||